EdwardLewisLainMDMBA

Acne & Rosacea, Cosmetic Dermatology, Dermatologic Surgery, Pediatric Dermatology

Fellow of American Academy of Dermatology. Chief Medical Officer, Sanova Dermatology Executive Director, Austin Institute for Clinical Research

Join to view full profile

Dr. Lain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lain's full profile

Already have an account?

Office
4300 N Quinlan Park Rd
Austin, TX 78732
Phone+1 512-266-0007

Fax+1 512-266-0077
Is this information wrong?

Summary

Dr. Edward Lain is a dermatologist in Austin, TX. He received his medical degree from Baylor College of Medicine and has been in practice 15 years. He specializes in acne & rosacea, cosmetic dermatology, dermatologic surgery, and pediatric dermatology and is experienced in dermatologic surgery, cosmetic dermatology, pediatric dermatology, mohs micrographic surgery, and laser resurfacing/fractional laser resurfacing.

Education & Training

University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Dermatology, 2003 - 2006
University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Internal Medicine, 2002 - 2003
Rice University Jesse H Jones Graduate School of ManagementMBA, Healthcare Administration, 2000 - 2002
Baylor College of MedicineClass of 2002

Certifications & Licensure

TX State Medical License 2005 - 2024
AR State Medical License 2004 - 2007
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
Completed
Phase 2
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris Start of enrollment: 2014 Aug 01
Completed
Phase 4
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis Start of enrollment: 2016 Apr 01
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing.
Yuling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz-Brugués, Aline Stennevin> ;Dermatology and Therapy. 2024 Mar 1
1 citations
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B Forman, Melinda Gooderham, Lawrence Green, Scott T Guenth...> ;Journal of the American Academy of Dermatology. 2024 May 1
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
Linda Stein Gold, Edward Lain, James Q Del Rosso, Michael Gold, Zoe D Draelos, Lawrence F Eichenfield, Neil Sadick, William P Werschler, Melinda J Gooderham, Mary Lupo> ;Journal of the American Academy of Dermatology. 2023 Nov 1
Evaluation of a retinol containing topical treatment to improve signs of neck aging.
Kelly Sullivan, Robert M Law, Edward Lain, Lily I Jiang, Summer F Acevedo, Hina Choudhary, Brittany Lee, Komal Patel, Stephen Lynch> ;Journal of Cosmetic Dermatology. 2023 Oct 1
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Leon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, Michael Bukhalo, Alim R Devani, Zoe D Draelos, Janet DuBois, Melinda J Gooderham, Steven E Kempers, Edward Lain, ...> ;The British Journal of Dermatology. 2023 Sep 15
2 citations
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Matthew J Zirwas, Zoe D Draelos, Janet DuBois, Leon H Kircik, Angela Y Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, ...> ;JAMA Dermatology. 2023 Jun 1
2 citations
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
Lawrence F Eichenfield, Linda Stein Gold, Leon H Kircik, William P Werschler, Kenneth Beer, Zoe D Draelos, Emil A Tanghetti, Kim A Papp, Hilary Baldwin, Edward Lain, N...> ;Pediatric Dermatology. 2023 Mar 22
7 citations
Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines.
John H Joseph, Corey Maas, Melanie D Palm, Edward Lain, Dee Anna Glaser, Suzanne Bruce, Steven Yoelin, Sue Ellen Cox, Steven Fagien, Sara Sangha, John Maltman, Xiaofan...> ;Aesthetic Surgery Journal. 2022 Oct 13
15 citations
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
Ellen J Kim, Aaron R Mangold, Jennifer A DeSimone, Henry K Wong, Lucia Seminario-Vidal, Joan Guitart, James Appel, Larisa Geskin, Edward Lain, Neil J Korman, Nathalie ...> ;JAMA Dermatology. 2022 Sep 1
Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series.
James Q Del Rosso, Edward Lain, Jean Philippe York, Andrew Alexis> ;Dermatology and Therapy. 2022 Sep 1
1 citations
Evaluation of Psychological Wellbeing and Social Impact of Combined Facial and Truncal Acne: a Multi-national, Mixed-Methods Study.
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, Rajeev Chavda, Julie Harper, Adelaide Hebert, Edward Lain, Alison Layton, Marco Rocha, Jonathan Weiss, Brigitte Dréno> ;Dermatology and Therapy. 2022 Aug 1
3 citations
A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris.
James Q Del Rosso, Sandra Marchese Johnson, Todd Schlesinger, Lawrence Green, Nestor Sanchez, Edward Lain, Zoe Draelos, Jean-Philippe York, Rajeev Chavda> ;The Journal of Clinical and Aesthetic Dermatology. 2022 Jul 1
4 citations
Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes.
Lawrence J Green, Edward Lain, Thomas Prunty, Robert Rhoades> ;The Journal of Clinical and Aesthetic Dermatology. 2022 May 1
8 citations
Evaluation of psychological well-being and social impact of atrophic acne scarring: A multinational, mixed-methods study.
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, Rajeev Chavda, Julie Harper, Adelaide Hebert, Edward Lain, Alison Layton, Marco Rocha, Jonathan Weiss, Brigitte Dréno> ;JAAD International. 2022 Mar 1
5 citations
Meibomian Gland Dysfunction: A Dermatological Perspective on Pathogenesis and Treatment Outlook
Preeya K. Gupta, Laura M Periman, Edward Lain, Eric D. Donnenfeld, John A. Hovanesian, Terry Kim, William Trattler, Elizabeth Yeu, Edward J. Holland> ;Clinical Ophthalmology. 2021 Nov 9
18 citations
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey.
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, Rajeev Chavda, Julie C Harper, Adelaide A. Hebert, Edward Lain, Alison M. Layton, Marco Rocha, Jonathan S. Weiss, Brigitt...> ;American Journal of Clinical Dermatology. 2021 Oct 27
12 citations
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study...
Linda Stein Gold, Hilary Baldwin, Leon H Kircik, Jonathan S. Weiss, David M. Pariser, Valerie D. Callender, Edward Lain, Michael A. Gold, Kenneth Beer, Zoe Diana Drael...> ;American Journal of Clinical Dermatology. 2021 Oct 21
18 citations
Impact of facial and truncal acne on quality of life: A multi-country population-based survey.
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, Rajeev Chavda, Julie C Harper, Adelaide A. Hebert, Edward Lain, Alison M. Layton, Marco Rocha, Jonathan M. Weiss, Brigitt...> ;JAAD International. 2021 Apr 27
6 citations
Safety and Efficacy of Nano-Pulse Stimulation Treatment of Non-Genital, Cutaneous Warts (Verrucae).
Richard Nuccitelli, Brenda M LaTowsky, Edward Lain, Girish S. Munavalli, Lesley Loss, E. Victor Ross, Lauren Jauregui, William A Knape> ;Lasers in Surgery and Medicine. 2021 May 19
25 citations
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials.
Brett A. King, Catherine Maari, Edward Lain, Jonathan I. Silverberg, Maher Issa, Katrin Holzwarth, Dennis Brinker, Tracy Cardillo, Fabio P. Nunes, Eric L. Simpson> ;American Journal of Clinical Dermatology. 2021 Apr 7
1 citations
Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Preadolescent Patients: A Phase IV, Open-label, 12-week Study.
Angela Yen Moore, Edward Lain, Amy J. McMichael, Leon H Kircik, Andrea L. Zaenglein, Adelaide A. Hebert, Ayman Grada> ;The Journal of Clinical and Aesthetic Dermatology. 2021 Apr 1
5 citations
Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens.
Hilary Baldwin, Andrew F Alexis, Anneke Andriessen, Diane Berson, Patricia K. Farris, Julie C Harper, Edward Lain, Shari Marchbein, Linda Stein Gold, Jerry Tan> ;Journal of Drugs in Dermatology. 2021 Apr 1
47 citations
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Andrew Blauvelt, Steven Kempers, Edward Lain, Todd Schlesinger, Stephen K. Tyring, Seth Forman, Glynis Ablon, George R. Martin, Hui Wang, David Lawrence Cutler, Jane F...> ;The New England Journal of Medicine. 2021 Feb 10
6 citations
Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis
David M. Pariser, Edward Lain, Richard D. Mamelok, Janice Drew, Diane R. Mould> ;Clinical Pharmacokinetics. 2021 Jan 12
3 citations
Effects of Tazarotene 0.045% Lotion on Quality of Life in Patients With Moderate-to-Severe Acne.
Leon H Kircik, Edward Lain, Michael A. Gold, Bruce E. Katz, Hilary Baldwin, Eric Guenin, Anya Loncaric, Radhakrishnan Pillai> ;Journal of Drugs in Dermatology. 2020 Nov 1
Join now to see all

Lectures

Late-breaking Research: Clinical Trials
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Press Mentions

Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual MeetingMarch 4th, 2019
Galderma Announces Positive Results from the “CoMMPlete” Regimen Study Including Epiduo® Gel in the Management of Acne in Adolescent Student AthletesMay 24th, 2016